Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patients.
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) resulted in millions of deaths globally. Adults with immunosuppression (e.g., solid organ transplant recipients) and those undergoing active cancer treatments experience worse infections and more severe...
Saved in:
| Main Authors: | Sonia T Gazeau, Xiaoyan Deng, Elsa Brunet-Ratnasingham, Daniel E Kaufmann, Catherine Larochelle, Penelope A Morel, Jane M Heffernan, Courtney L Davis, Amber M Smith, Adrianne L Jenner, Morgan Craig |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-06-01
|
| Series: | PLoS Computational Biology |
| Online Access: | https://doi.org/10.1371/journal.pcbi.1013170 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transcriptomic profiling of severe and critical COVID-19 patients reveals alterations in expression, splicing and polyadenylation
by: Marjorie Labrecque, et al.
Published: (2025-04-01) -
Refractory Giardiasis in an Immunosuppressed Patient in Turkey
by: Filiz Kaya, et al.
Published: (2018-03-01) -
Checkpoint inhibitor therapy in immunosuppressed patients with Merkel cell carcinoma: not all immunosuppression is created equal
by: Andrew S Brohl
Published: (2025-03-01) -
A new approach to immunosuppressive therapy in patients with glomerulonephritis with nephrotic syndrome
by: S. I. Kudryashov, et al.
Published: (2024-01-01) -
Comparative effectiveness of various immunosuppressive therapy regimens for uveitis in patients with Behçet’s disease
by: T. A. Lisitsyna, et al.
Published: (2021-05-01)